Journal
/
Biology
/
CRISPR/Cas9 Genredigering av hematopoietiske stamceller og stamceller for genterapiapplikasjoner…
A subscription to JoVE is required to view this content.
CRISPR/Cas9 Genredigering av hematopoietiske stamceller og stamceller for genterapiapplikasjoner
The JoVE video player is compatible with HTML5 and Adobe Flash. Older browsers that do not support HTML5 and the H.264 video codec will still use a Flash-based video player. We recommend downloading the newest version of Flash here, but we support all versions 10 and above.
If that doesn't help, please let us know.
Unable to load video. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
An unexpected error occurred. Please check your Internet connection and reload this page. If the problem continues, please let us know and we'll try to help.
Click here for the English version
Article
DOI:
10.3791/64064-v
•
08:32 min
•
August 9th, 2022
CRISPR/Cas9 Genredigering av hematopoietiske stamceller og stamceller for genterapiapplikasjoner
August 9th, 2022
•
Vigneshwaran Venkatesan*1,2, Abisha Crystal Christopher*1,3, Karthik V. Karuppusamy1,2, Prathibha Babu1,2, Manoj Kumar K. Alagiri1,2, Saravanabhavan Thangavel1
1Centre for Stem Cell Research (CSCR), A unit of InStem Bengaluru, Christian Medical College campus, 2Manipal Academy of Higher Education, 3Thiruvalluvar University
* These authors contributed equally
Chapters
Summary
Please note that all translations are automatically generated.
Click here for the English version.
Den nåværende protokollen beskriver en optimalisert hematopoietisk stamme og stamcelle (HSPC) kulturprosedyre for robust engraftment av genredigerte celler in vivo.